HRTX

Heron Therapeutics (HRTX)

About Heron Therapeutics (HRTX)

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.

Details

Daily high

$0.52

Daily low

$0.47

Price at open

$0.50

52 Week High

$1.58

52 Week Low

$0.38

Market cap

94.5M

Dividend yield

0.00%

Volume

2.1M

Avg. volume

2.2M

P/E ratio

-2.83

Heron Therapeutics News